Glutamate oxaloacetate transaminase 2 (GOT2) has been repeatedly reported in recent years to be associated with the progression of pancreatic cancer,47, 48 but its role in HCC remains unclear. The gene discussed is GOT2; the disease is pancreatic neoplasm.